Adrafinil

  Cat. No.:  DC24002   Featured
Chemical Structure
63547-13-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
The prodrug of modafinil that is a mild central nervous system stimulant drug used to relieve excessive sleepiness and inattention..
Cas No.: 63547-13-7
Chemical Name: Adrafinil
Synonyms: Adrafinil;2-[(DIPHENYLMETHYL)SULFINYL]ACETOHYDROXAMIC ACID;CRL 40028;OLMIFON;2-((diphenylmethyl)sulfinyl)-acetohydroxamicaci;2-((diphenylmethyl)sulfinyl)-n-hydroxy-acetamid;2-((diphenylmethyl)sulfinyl)-n-hydroxyacetamide;2-(benzhydrylsulfinyl)acetohydroxamicacid;ADRAFINIL (OLMIFON);2-[(Diphenylmethyl)sulfinyl]acetohydroxamic acid, CRL 40028, Olmifon;2-[(Diphenylmethyl)sulfinyl]-N-hy-dmxyacetamide;Acetohydroxamic acid, 2-((diphenylmethyl)sulfinyl)-;(Benzhydrylsulfinyl)acetohydroximic acid;2-benzhydrylsulfinyl-N-hydroxyacetamide;Acetamide,2-[(diphenylmethyl)sulfinyl]-N-hydroxy-;[2-(diphenyl)methanesulfinyl]-N-hydroxy-acetamide;2-(benzhydrylsulphinyl)acetohydroxamic acid;Acetamide,2-((diphenylmethyl)sulfinyl)-N-hydroxy;benzhydrylsulphinyl-acetohydroxamic acid;Adrafinil [INN];Adrafinilum [INN-Latin];2-[(Diphenylmethyl)sulfinyl]-N-hydroxyacetamide;2-(Benzhydrylsulfinyl)acetohydroxamic acid;C15H15NO3S;2-((Diphenylmethyl)sulfinyl)acetohydroxamsaeure;Adrafinil (INN);Acetamide, 2-((diphenylmethyl)sulfinyl)-N-hydroxy-;NCGC00165714-;HMS3886M15;HMS3886M15;s5224;63547-13-7;s5224;AB07489;63547-13-7;2-(BENZHYDRYLSULFINYL)-N-HYDROXYACETAMIDE;AB07489;2-(BENZHYDRYLSULFINYL)-N-HYDROXYACETAMIDE;SCHEMBL49334;SCHEMBL49334;DTXCID2026498;DTXCID2026498;BI81Z4542G;BI81Z4542G;NCGC00165714-02;NCGC00165714-02;2-((Diphenylmethyl)sulfinyl)-N-hydroxyacetamide;2-((Diphenylmethyl)sulfinyl)-N-hydroxyacetamide;HY-17549;ADRAFINIL [MI];HY-17549;ADRAFINIL [WHO-DD];ADRAFINIL [MI];1ST10934;ADRAFINIL [WHO-DD];Adrafinilum;1ST10934;Acetamide, 2-[(S)-(diphenylmethyl)sulfinyl]-N-hydroxy-;Adrafinilum;NS00007283;Acetamide, 2-[(S)-(diphenylmethyl)sulfinyl]-N-hydroxy-;CAS-63547-13-7;NS00007283;DTXSID4046498;CAS-63547-13-7;MFCD00865357;DTXSID4046498;EINECS 264-303-1;MFCD00865357;UNII-BI81Z4542G;EINECS 264-303-1;2-((Diphenylmethyl)sulfinyl)acetohydroxamic acid;UNII-BI81Z4542G;NCGC00165714-01;2-((Diphenylmethyl)sulfinyl)acetohydroxamic acid;CRL-40028;NCGC00165714-01;Q366482;CRL-40028;CCG-267371;Q366482;Olmifon;CCG-267371;Olmifon;CHEBI:135200;CHEBI:135200;Adrafinil, >=98% (HPLC), solid;Adrafinil, >=98% (HPLC), solid;D07348;D07348;Acetamide, 2-((S)-(diphenylmethyl)sulfinyl)-N-hydroxy-;Acetamide, 2-((S)-(diphenylmethyl)sulfinyl)-N-hydroxy-;AF-0056;AF-0056;ADRAFINIL [MART.];W-104904;ADRAFINIL [MART.];AKOS015994532;W-104904;2-[(Diphenylmethyl)sulfinyl]acetohydroxamic acid;AKOS015994532;2-[(Diphenylmethyl)sulfinyl]acetohydroxamic acid;F17382;F17382;Adrafinil, (S)-;Adrafinil, (S)-;BRN 1990030;BRN 1990030;ADRAFINIL [NFLIS-DRUG];EX-A733;ADRAFINIL [NFLIS-DRUG];EX-A733;ADRAFINIL;ADRAFINIL;827603-96-3;827603-96-3;Tox21_112258;Olmifon (TN);Tox21_112258;CHEMBL93077;Olmifon (TN);CHEMBL93077
SMILES: S(C([H])([H])C(N([H])O[H])=O)(C([H])(C1C([H])=C([H])C([H])=C([H])C=1[H])C1C([H])=C([H])C([H])=C([H])C=1[H])=O
Formula: C15H15NO3S
M.Wt: 289.3495
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: The prodrug of modafinil that is a mild central nervous system stimulant drug used to relieve excessive sleepiness and inattention.
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC31074 Isopropyl myristate Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC74557 PREX-in1 PREX-in1 is a specific small-molecule inhibitor of P-Rex1 and P-Rex2 Rac-GEF activity with IC50 of 4.5 uM (P-Rex1 DHPH Rac-GEF activity) in liposome-based GEF assay, inhibits P-Rex1 and P-Rex2 through their catalytic DH domain.
DC74555 GYS32661 GYS32661 (GYS 32661) is a potent Rac inhibitor capable of inhibiting both Rac1 and Rac1b, inhibited activated Rac1 with IC50 of 1.18 uM in in vitro pull-down assays.
DC74539 L557-0155 L557-0155 is a small molecule inhibitor of VSIG-8, prevents VSIG-8 binding to VISTA, promotes cytokine production and cell proliferation in PBMCs and suppresses melanoma growth.
DC74528 K284 K284 is a selective small molecule inhibitor of chitinase 3 like1 (CHI3L1) with strong binding affinity (Kd=-9.7 kcal·mol-1), inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals.
DC74225 YB-537 YB-537 (YB537) is a potent, highly specific quinone reductase 2 (QR2) inhibitor with IC50 of 3 nM, shows no activity against QR1 (IC50>10 uM).
DC74223 X-Neu5Ac X-Neu5Ac (sodium) is a substrate for chromogenic assay of neuraminidase activity in bacterial expression systems; with a Km of 0.89 mM for neuraminidase.
DC74218 UT-59 UT-59 is a specific inhibitor of cholesterol-sensing membrane protein Scap, binds to Scap's cholesterol-binding site, blocks SREBP activation and inhibits lipid synthesis.
DC74205 Tryptolinamide Tryptolinamide (TLAM) is a small-molecule compound that activates mitochondrial respiration in cybrids generated from patient-derived mitochondria and fibroblasts from patient-derived iPSCs, inhibits phosphofructokinase-1 (PFK1) with an ATP-uncompetitive
DC74203 TR-107 TR-107 (TR107) is a highly potent, selective and orally bioavailable small-molecule activator of the mitochondrial protease ClpP with EC50 of 140 nM, binds to purified ClpP with Kd value of 180 nM in surface plasmon resonance (SPR) measurement.
X